D.E. Shaw & Co’s Olema Pharmaceuticals OLMA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q1 | – | Sell |
-12,445
| Closed | -$72.6K | – | 3248 |
|
2024
Q4 | $72.6K | Sell |
12,445
-13,148
| -51% | -$76.7K | ﹤0.01% | 2823 |
|
2024
Q3 | $306K | Buy |
25,593
+4,534
| +22% | +$54.1K | ﹤0.01% | 2678 |
|
2024
Q2 | $228K | Buy |
21,059
+10,959
| +109% | +$119K | ﹤0.01% | 2794 |
|
2024
Q1 | $114K | Sell |
10,100
-1,789
| -15% | -$20.3K | ﹤0.01% | 2818 |
|
2023
Q4 | $167K | Buy |
+11,889
| New | +$167K | ﹤0.01% | 2713 |
|
2022
Q3 | – | Sell |
-154,081
| Closed | -$627K | – | 4091 |
|
2022
Q2 | $627K | Sell |
154,081
-58,289
| -27% | -$237K | ﹤0.01% | 2939 |
|
2022
Q1 | $905K | Buy |
212,370
+124,288
| +141% | +$530K | ﹤0.01% | 2933 |
|
2021
Q4 | $824K | Buy |
88,082
+20,656
| +31% | +$193K | ﹤0.01% | 2854 |
|
2021
Q3 | $1.86M | Buy |
67,426
+26,622
| +65% | +$734K | ﹤0.01% | 2141 |
|
2021
Q2 | $1.14M | Sell |
40,804
-75,725
| -65% | -$2.12M | ﹤0.01% | 2420 |
|
2021
Q1 | $3.87M | Buy |
+116,529
| New | +$3.87M | ﹤0.01% | 1490 |
|